WallStreetZenWallStreetZen

NASDAQ: VYGR
Voyager Therapeutics Inc Stock Ownership - Who owns Voyager Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Voyager Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alfred SandrockPresident and CEO2026-04-0211,511$3.87
$44.55kSell
Nathan D. JorgensenChief Financial Officer2026-02-244,668$3.77
$17.60kSell
Todd Alfred CarterChief Scientific Officer2026-02-244,174$3.76
$15.69kSell
Alfred SandrockPresident and CEO2026-02-2414,197$3.79
$53.81kSell
Robin SwartzCOO CBO2026-02-246,458$3.77
$24.35kSell
Alfred SandrockPresident and CEO2026-02-1811,732$3.41
$40.01kSell
Robin SwartzCOO CBO2026-02-183,882$3.44
$13.35kSell
Todd Alfred CarterChief Scientific Officer2026-02-183,301$3.44
$11.36kSell
Alfred SandrockPresident and CEO2026-02-1012,192$3.78
$46.09kSell
Todd Alfred CarterChief Scientific Officer2026-02-103,525$3.85
$13.57kSell

1 of 2

VYGR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VYGR insiders and whales buy or sell their stock.

VYGR Shareholders

What type of owners hold Voyager Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Neurocrine Biosciences Inc14.19%8,575,316$30.27MInsider
Ecor1 Capital LLC13.45%8,128,014$28.69MInsider
Mark J. Levin10.64%6,427,874$22.69MInsider
Blackrock Inc9.22%5,568,381$19.66MInstitution
Armistice Capital LLC5.79%3,500,000$12.36MInstitution
Millennium Management LLC5.67%3,428,571$12.10MInstitution
Vestal Point Capital LP4.97%3,002,936$10.60MInstitution
Sanofi4.10%2,477,941$8.75MInsider
Vanguard Capital Management LLC3.78%2,283,253$8.06MInstitution
Opaleye Management Inc1.90%1,150,000$4.06MInstitution

1 of 3

VYGR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VYGR53.04%46.96%Net SellingNet Selling
ARTV49.72%50.28%Net BuyingNet Buying
FHTX75.69%14.46%
HELP48.32%0.00%
LENZ52.97%47.03%Net SellingNet Buying
View Top Biotech Stocks

Voyager Therapeutics Stock Ownership FAQ

Who owns Voyager Therapeutics?

Voyager Therapeutics (NASDAQ: VYGR) is owned by 55.47% institutional shareholders, 49.11% Voyager Therapeutics insiders, and 0.00% retail investors. Neurocrine Biosciences Inc is the largest individual Voyager Therapeutics shareholder, owning 8.58M shares representing 14.19% of the company. Neurocrine Biosciences Inc's Voyager Therapeutics shares are currently valued at $29.84M.

If you're new to stock investing, here's how to buy Voyager Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.